ENTRY       D06889                      Drug
NAME        Pegfilgrastim (USAN/INN);
            Pegfilgrastim (genetical recombination) (JAN);
            Pegfilgrastim (genetical recombination) [Pegfilgrastim biosimilar 1] (JAN);
            Pegfilgrastim-cbqv;
            Pegfilgrastim-bmez;
            Neulasta (TN);
            G-lasta (TN);
            Udenyca (TN)
PRODUCT     FULPHILA (Biocon Biologics)
            FULPHILA (Mylan Institutional LLC)
            FYLNETRA (Amneal Pharmaceuticals LLC)
            NEULASTA (Amgen)
            NYVEPRIA (Pfizer Laboratories Div Pfizer)
            STIMUFEND (Fresenius Kabi USA)
            UDENYCA (Coherus BioSciences)
            ZIEXTENZO (Sandoz)
FORMULA     C849H1347N223O244S9. (C2H4O)n
SEQUENCE    MTPLGPASSL PQSFLLKCLE QVRKIQGDGA ALQEKLCATY KLCHPEELVL LGHSLGIPWA
            PLSSCPSQAL QLAGCLSQLH SGLFLYQGLL QALEGISPEL GPTLDTLQLD VADFATTIWQ
            QMEELGMAPA LQPTQGAMPA FASAFQRRAG GVLVASHLQS FLEVSYRVLR HLAQP
            (Disulfide bridge: 37-43, 65-75)
  TYPE      Peptide
CLASS       Immunological agent
             DG01753  Colony stimulating factor
              DG01781  Granulocyte colony stimulating factor (G-CSF)
REMARK      Therapeutic category: 3399
            ATC code: L03AA13
            Product: D06889<JP/US>
EFFICACY    Antineutropenic, Hematopoietic stimulant, Granulocyte colony stimulating factor (G-CSF)
  DISEASE   Febrile neutropenia [DS:H00100]
COMMENT     recombinant granulocyte colony stimulating factor (G-CSF) [HSA:1440] [KO:K05423]
TARGET      CSF3R (GCSFR, CD114) [HSA:1441] [KO:K05061]
  PATHWAY   hsa04060(1441)  Cytokine-cytokine receptor interaction
            hsa04151(1441)  PI3K-Akt signaling pathway
            hsa04630(1441)  JAK-STAT signaling pathway
            hsa04640(1441)  Hematopoietic cell lineage
            hsa05200(1441)  Pathways in cancer
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L03 IMMUNOSTIMULANTS
               L03A IMMUNOSTIMULANTS
                L03AA Colony stimulating factors
                 L03AA13 Pegfilgrastim
                  D06889  Pegfilgrastim (USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Immunological Agents
              Immunostimulants
               Colony-stimulating Factors
                Pegfilgrastim
                 D06889  Pegfilgrastim (USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              33  Blood and body fluid agents
               339  Miscellaneous
                3399  Others
                 D06889  Pegfilgrastim (USAN/INN); Pegfilgrastim (genetical recombination) (JAN); Pegfilgrastim (genetical recombination) [Pegfilgrastim biosimilar 1] (JAN)
            Drug groups [BR:br08330]
             Immunological agent
              DG01753  Colony stimulating factor
               DG01781  Granulocyte colony stimulating factor (G-CSF)
                D06889  Pegfilgrastim
            Drug classes [BR:br08332]
             Immunological agent
              DG01753  Colony stimulating factor
               D06889  Pegfilgrastim
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               CSF and other factor receptors
                CSF3R (GCSFR, CD114)
                 D06889  Pegfilgrastim (USAN/INN) &lt;JP/US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D06889
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D06889
DBLINKS     CAS: 208265-92-3
            PubChem: 49661789
///
